Eye Drop

Eye Drop Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 11 adverse event reports referencing Eye Drop, including 3 reports in which the animal died — a 2730.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Eye Drop. Reported administration routes include Intraocular, Unknown, Ophthalmic. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Eye Drop reports are Dog (7 reports), Cat (4 reports), with Dog accounting for the largest share. Within those species, Spitz - German Pomeranian (2), Retriever - Labrador (2), Domestic Shorthair (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Eye Drop are Heart murmur (3), Not eating (3), Weight loss (3), Congestive heart failure (2). Of the 11 reports with a coded outcome, Ongoing is the leading category at 36.4%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Eye Drop.